China Universal Asset Management »

Krystal Biotech shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $972k 5.5k 177.92
2023-12-31 $404k 3.3k 123.96
2023-09-30 $83k 718 115.60
2023-06-30 $40k 339 117.99
2023-03-31 $28k 349 80.23
2022-12-31 $21k 262 80.15
2022-09-30 $17k 240 70.83

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Krystal Biotech

venBio Select Advisor
Vanguard Group
Redmile Group
Frazier Life Sciences Management
Jennison Associates
Dimensional Fund Advisors
Ikarian Capital
Lord, Abbett & Co
Credit Suisse
Susquehanna International
T. Rowe Price Associates
Balyasny Asset Management
Goldman Sachs Group
Jpmorgan Chase & Co
Braidwell

View all funds holding Krystal Biotech